EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience

Dae Hee Kim, Jinu Han, Kyung-Ah Park, Hee Kyung Yang, Ungsoo Samuel Kim, Seung-Hyun Kim, Hae Jung Paik

Korean Journal of Ophthalmology · 2025

DOI: 10.3341/kjo.2025.0039 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Korean Journal of Ophthalmology, 2025. Verfasst von Dae Hee Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kim's Eye Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Atropine, Refraction, Ocular, Visual Acuity, Myopia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the effectiveness of 0.125% atropine eye drops in controlling myopia progression by analyzing 1-year follow-up data through a multicenter retrospective study in South Korea.

Methods

A retrospective chart review was conducted across five centers, including 121 myopic children (aged 4–11 years) treated with 0.125% atropine between January 2021 and December 2023. An equal number of age-, sex-, axial length (AL)-, and spherical equivalent (SE)-matched untreated individuals (control group) were included. Baseline and follow-up data at 6 and 12 months included visual acuity, autorefraction, AL measurement (IOLMaster 700), and fundus examination. The primary outcome measures were changes in SE and AL compared to controls.

Results

Age, SE, and AL in the treatment group at baseline were 7.5 ± 1.5 years (range, 4 to 11), –3.07 ± 1.65 diopters (D; range, –0.25 to –5.88 D), and 24.39 ± 0.85 mm (range, 22.19 to 26.94 mm), respectively, and these parameters showed no statistical differences compared to the matched controls. SE after 1-year treatment was less myopic in the treatment group (–3.42 ± 1.72 D vs. –3.94 ± 1.92 D, p = 0.019). Similarly, AL was significantly shorter in treatment group compared to the control group (24.65 ± 0.88 mm vs. 24.88 ± 0.80 mm, p = 0.031). The SE change from baseline was –0.33 ± 0.73 D in the treatment group versus –0.91 ± 1.01 D in the control group (p < 0.001). AL increased by 0.25 ± 0.32 mm in the treatment group, significantly less than 0.49 ± 0.24 mm increase in the control group (p < 0.001). Baseline AL and mean keratometry showed no correlation with AL progression (all p > 0.05).

Conclusions

The use of 0.125% atropine eye drops significantly reduced myopia progression, with approximately 50% reduction in AL elongation compared to controls. Given its effectiveness and variable compliance, 0.125% atropine eye drops may serve as a viable alternative to low-dose atropine for myopia control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtropineRefraction, OcularVisual AcuityMyopiaHumansRetrospective StudiesMaleChildFemaleRepublic of KoreaChild, PreschoolOphthalmic SolutionsFollow-Up StudiesMydriaticsTreatment OutcomeDisease ProgressionAdministration, TopicalAxial Length, EyeDose-Response Relationship, Drug

Stichwörter der Autor:innen

AtropineAxial lengthMyopia

Substanzen

AtropineOphthalmic SolutionsMydriatics

Autor:innen und Institutionen

  • Department of Ophthalmology, Kim's Eye Hospital, Seoul, Korea.
  • Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Department of Ophthalmology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
  • Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea.

Zitieren

APA

Kim, D. H., Han, J., Park, K. A., Yang, H. K., Kim, U. S., Kim, S. H., & Paik, H. J. (2025). Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2025.0039

Vancouver

Kim DH, Han J, Park KA, Yang HK, Kim US, Kim SH, et al. Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience. Korean Journal of Ophthalmology. 2025. doi:10.3341/kjo.2025.0039

BibTeX
@article{Kim2025,
  author = {Kim, Dae Hee and Han, Jinu and Park, Kyung-Ah and Yang, Hee Kyung and Kim, Ungsoo Samuel and Kim, Seung-Hyun and Paik, Hae Jung},
  title = {Therapeutic Effect of Topical 0.125% Atropine in South Korean Myopic Children: A Real-World Experience},
  journal = {Korean Journal of Ophthalmology},
  year = {2025},
  doi = {10.3341/kjo.2025.0039}
}
Kostenlos starten →